Anthera's cystic fibrosis drug fails late-stage study, shares tank
Dec 27 (Reuters) - Anthera Pharmaceuticals Inc said on Tuesday that its drug to treat certain cystic fibrosis patients failed a late-stage study, sending the company's shares tumbling nearly 70... [Source]
Publication Date:Origin: reuters.com
Category: hotStocksNews
Topics: study, late-stage, cystic, nearly, shares tumbling, company's, sending, failed, fibrosis patients, certain, treat, said on, Pharmaceuticals, Anthera, (Reuters), shares, fails, fibrosis, Anthera's
Source: http://feeds.reuters.com/~r/reuters/hotStocksNews/~3/zwRifcC9s2A/anthera-study-idUSL4N1EM3HN